v3 Template
I

Iktos

Biotechnology / Drug Discovery ~600 employees
Founded
--
Employees (Est.)
~600
30 leaders known
Total Funding
$19.3M
Funding Rounds
2
Last Funding
2025-02-20

About Iktos

Iktos is a company pioneering the use of AI and robotics to transform drug discovery. Their mission is to accelerate the development of new treatments to improve patient care by integrating generative AI with automated synthesis and testing, aiming for fully autonomous labs.

Products & Services

Makya:A generative AI SaaS platform designed for chemists, focusing on creating novel, synthetically accessible molecules with multi-parametric optimization and 3D constraints.
Spaya:An AI-driven retrosynthesis platform that identifies feasible synthetic routes from target compounds to commercially available materials, with customizable synthesis steps.
Iktos Robotics Chemistry:An autonomous lab system for fully automated synthesis and analysis, managing the complete synthetic process and high-throughput data generation.
Iktos Robotics Biology:A platform using multidimensional biological data for in-cellulo screening, identifying small-molecule modulators for protein and RNA interactions.
Discovery Collaboration:Services to accelerate the development of new drug candidates through partnerships with pharmaceutical, biotech, and academic institutions.

Specialties

Generative AI Retrosynthesis AI Robotics in Drug Discovery Autonomous Labs Molecular Design Synthesis Planning Biological Data Screening

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 2750000
MR: -
FA: €2.5 million
FAN: 2750000
D: 2025-02-20
FD: 2025-02-20
1 investors
2 RT: Series A
T: -
FT: Series A
A: 16585000
MR: -
FA: € 15.5m
FAN: 16585000
D: 2023-03-09
FD: 2023-03-09
3 investors
Grant Latest
2025-02-20
$2.8M
1 investor (Pro only)
Series A 2023-03-09
$16.6M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

Y

Yann Gaston-Mathé

Co-Founder & CEO | Board member

Q

Quentin Perron

Co-Founder & CSO | Board Observer

N

Nicolas Do Huu

Co-Founder & CTO | Board Member

R

Roman Fleck

Chairman of the Board

B

Bertrand Ducrey

Board Member

N

Nadiya Ishnazarova

Board Member

View 27 more team members with Pro

Unlock Full Team Directory

Recent News

Iktos Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
iktos.ai
Industries
Biotechnology / Drug Discovery
Company Size
~600 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro